Le Lézard
Classified in: Health, Science and technology, Business
Subjects: LIC, VET, DEI

U.S. Air Force and SimX Expand Their VR Medical Training Partnership to $12 Million in R&D Funding


SAN FRANCISCO, Feb. 9, 2023 /PRNewswire/ -- SimX and the U. S. Air Force are announcing a $1.7M expansion of its ongoing effort to advance the future of medical simulation training using virtual reality (VR) technology. This effort, housed within the Virtual Advancement of Learning for Operational Readiness (VALOR) program at SimX, aims to enhance the usability and medical capability of virtual simulation training, with a focus on prehospital combat casualty care delivered by the Air Force's elite special operations medical personnel.

The project includes a substantial expansion of VR medical simulation training into areas never previously trained using immersive technology, including advanced airway and ventilator management, extrication tools, enhanced portable monitors and ultrasound capabilities, and an improved physiological model for field sedation and paralysis. Additionally, the project aims to substantially increase the reliability and ease of use of VR simulation across the global scope of deployment of technology, including automated self-serve familiarization and simplified training orchestration. "We couldn't be more excited about this project," said Karthik V Sarma PhD, Principal Investigator of the effort and Chief Technology Officer of SimX, "which will accelerate the rapid advancement of VR medical simulation technology as a crucial modality for training healthcare workers in every setting."

The SimX Virtual Reality Medical Simulation System (VRMSS) is widely deployed across the Air Force for use in tactical combat casualty care (TCCC) training, as well as across hundreds of civilian medical organizations for training physicians, nurses, emergency medical technicians, pharmacists, and other professionals. Col Clayton Rabens, Wing Surgeon of the U.S. Air Force 24th Special Operations Wing, said "The enhanced casualty care training capabilities being developed under this project are essential to maintaining the highest level of readiness for a future of large-scale operations conducted against near-peer adversaries. The new capability to train these critical skills in a virtual domain will ensure that our elite operators continue to provide the highest level of care to US and partner force casualties."

Funding for this effort was provided by the Department of the Air Force (DAF) under the AFWERX/AFVentures Tactical Funding Increase (TACFI) ? Small Business Innovation Research (SBIR) program. The project is managed by the Air Force Life Cycle Management Center (AFLCMC) Special Operations Forces program office on behalf of the DAF.

About SimX 
SimX created an industry-leading virtual reality medical simulation platform that is used around the world and by top institutions including Mayo Clinic, Stanford, Northwestern, University of Pennsylvania, the US Air Force, and many others.  It allows trainees to work together in multiplayer virtual reality cases either together in the same space or from the safety of their own homes. SimX developed a unique system that allows for a "holodeck-like" experience without dropdown menus or virtual selections.  You talk and interact with virtual patients the same way that you would in real life.  The scalable SimX Scenario System allows for rapid development of new training materials and cases, and instant deployment to all learners. Learn more about the SimX System at simxvr.com.

About AFVentures
AFVentures invests in emerging technologies to scale Department of the Air Force capabilities, strengthening the US industrial base that empowers Airmen and Guardians by incentivizing private, for-profit investment in national security interests. Our success is achieved by connecting novel commercial solutions with defense problem sets, de-risking Airmen and Guardian initiatives to fill capability gaps and transition technologies. Learn more at https://afwerx.com/afventures-overview/.

Contact: 
Michael Werner
650-336-5754
[email protected]

SOURCE SimX


These press releases may also interest you

at 07:30
TUS Monotherapy and TUS+Venetoclax (VEN) Doublet Therapy Show Broad Clinical Activity and Strong Safety Data in relapsed or refractory (R/R) Acute Myeloid Leukemia (AML) and Differentiate TUS from other Investigational Drugs in AML TUS Monotherapy...

at 07:30
Soligenix, Inc. (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, announced today that Professor Axel Lehrer, University...

at 07:05
enGene Holdings Inc. , a clinical-stage genetic medicines company whose non-viral, intravesical lead product candidate, EG-70, is in a pivotal study for BCG-unresponsive high-risk non-muscle invasive bladder cancer (NMIBC), today announced its...

at 07:00
VersaBank , a North American leader in business-to-business digital banking, as well as technology solutions for cybersecurity, today announced that it has received approval from the Office of the Comptroller of the Currency (the "OCC"), the primary...

at 07:00
Syndax Pharmaceuticals (Nasdaq:...

at 07:00
Central Florida is the first location in the nation for a new pilot program that will explore new ways of learning for local preschoolers. Sponsored by The Early Learning Coalition of Orange County (ELCOC) and led by the Orlando-based Young...



News published on and distributed by: